Presentation Information
[2MS-05-04]Understanding the mechanisms of resistance to molecular-targeted drugs in lung cancer using patient derived samples and molecular-dynamic simulation
○Ryohei Katayama1,2 (1. Japanese Foundation for Cancer Research, 2. The University of Tokyo)
Password required to view
Log in
or
Comment
To browse or post comments, you must log in.Log in